ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag funding cancer clinical trials culture

Image showing monoclonal antibody treatment
The Resilience of Monoclonal Antibodies and their Makers
Laura Tran, PhD | Mar 15, 2024 | 10+ min read
The road to developing monoclonal antibodies for effectively targeting cancer was paved with tenacity, passion, and strokes of luck.
One Protein to Rule Them All
Shelby Bradford, PhD | Feb 28, 2024 | 10+ min read
p53 is possibly the most important protein for maintaining cellular function. Losing it is synonymous with cancer.
The Vaginal Microbiome is Finally Getting Recognized
Hannah Thomasy, PhD, Drug Discovery News | Sep 25, 2023 | 10+ min read
Vaginal dysbiosis has long been a taboo subject, but studying and optimizing the vaginal microbiome could be a game changer for women's health.
Human Clinical Trials Begin For Cervical Cancer Vaccines
Steve Bunk | Oct 26, 1997 | 6 min read
Efforts are under way to develop a vaccine against one of the world's deadliest illnesses, cervical cancer. Along with a number of university research laboratories, at least a half-dozen biotechnology and pharmaceutical companies are beginning clinical trials or are in preclinical development of such drugs. Efficacy in humans remains to be firmly established, but if the vaccines progress to later-phase trials, challenging jobs for immunologists, microbiologists, and biochemists will multiply. "
Bottom Line, Culture Clash Impeding Cooperation Of Managed-Care Organizations In Clinical Trials
Myrna Watanabe | Jun 23, 1996 | 10+ min read
Managed-Care Organizations In Clinical Trials RAY OF HOPE: Cancer-prevention specialist Jon Kerner says MCOs support Phase III trials in some cases. With the advent of managed-care organizations (MCOs) and their focus on cost competitiveness, academic scientists are concerned that clinical trials will suffer from decreased patient participation. MCOs, they say, have been refusing to pay for ancillary tests and procedures performed in the course of a trial that they would otherwise pay. Resear
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
An illustration of flowers in the shape of the female reproductive tract
Uterus Transplants Hit the Clinic
Jef Akst | Aug 1, 2021 | 10+ min read
With human research trials resulting in dozens of successful deliveries in the US and abroad, doctors move toward offering the surgery clinically, while working to learn all they can about uterine and transplant biology from the still-rare procedure.
Immunology Leader Vincenzo Cerundolo Dies
Ashley Yeager | Jan 16, 2020 | 2 min read
The Oxford researcher’s work on lipid and peptide antigens revealed key mechanisms in inflammation, immunotherapy, and vaccination, which are being pursued in clinical trial treatments.
Amid Criticism, NCI Tries To Boost Minority Clinical-Trial Recruitment
Myrna Watanabe | Apr 1, 1996 | 10+ min read
Clinical-Trial Recruitment 'PLEASANT SUPRISE': NCI's Otis Brawley notes the racial makeup of treatment-trial patients was not planned. The National Cancer Institute (NCI), the largest of the National Institutes of Health, proudly touts its record of recruiting minorities into clinical trials it supports. "We have incredibly good representation of minorities on treatment trials," maintains Otis Brawley, senior investigator in the Community Oncology and Rehabilitation Branch of NCI's Division o
Hard and Harder
Michael K. Gusmano | Jun 5, 2011 | 4 min read
The path to eradicating malaria in Africa involves much more than just a vaccine.

Run a Search

ADVERTISEMENT